139 related articles for article (PubMed ID: 8042882)
1. False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose.
Reinsberg J; Wagner U; Krebs D
Arch Gynecol Obstet; 1994; 255(1):9-18. PubMed ID: 8042882
[TBL] [Abstract][Full Text] [Related]
2. Falsely low results in CA 125 determination due to anti-idiotypic antibodies induced by infusion of [131I]F(ab')2 fragments of the OC125 antibody.
Reinsberg J; Nocke W
Eur J Clin Chem Clin Biochem; 1993 May; 31(5):323-7. PubMed ID: 8357942
[TBL] [Abstract][Full Text] [Related]
3. Monitoring cancer antigen 125 in serum of ovarian cancer patients after administration of 131I-labeled F(ab')2 fragments of OC125 antibody.
Reinsberg J; Schultes B; Wagner U; Krebs D
Clin Chem; 1993 May; 39(5):891-6. PubMed ID: 8485883
[TBL] [Abstract][Full Text] [Related]
4. Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetection.
Reinsberg J; Heydweiller A; Wagner U; Pfeil K; Oehr P; Krebs D
Clin Chem; 1990 Jan; 36(1):164-7. PubMed ID: 2297919
[TBL] [Abstract][Full Text] [Related]
5. Influence of human anti-murine antibodies on in vitro assays in ovarian cancer patients.
Hertel A; Baum R
Hybridoma; 1993 Oct; 12(5):571-6. PubMed ID: 8300132
[No Abstract] [Full Text] [Related]
6. Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Induction of antibodies against OC125 and CA125 after immunization with an anti-CA 125 (MAb OC125) monoclonal antibody by activation of the idiotypic network.
Schultes BC; Reinsberg J; Schlebusch H; Oehr P; Biersack HJ; Krebs D; Wagner U
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):427-32. PubMed ID: 8399782
[TBL] [Abstract][Full Text] [Related]
7. Human antibody response to the intravenous and intraperitoneal administration of the F(ab')2 fragment of the OC125 murine monoclonal antibody.
Maher VE; Drukman SJ; Kinders RJ; Hunter RE; Jennings J; Brigham C; Stevens S; Griffin TW
J Immunother (1991); 1992 Jan; 11(1):56-66. PubMed ID: 1734949
[TBL] [Abstract][Full Text] [Related]
8. Confirmation of a false-positive result in CA 125 immunoradiometric assay caused by human anti-idiotypic immunoglobulin.
Klug TL; Green PJ; Zurawski VR; Davis HM
Clin Chem; 1988 Jun; 34(6):1071-6. PubMed ID: 2454168
[TBL] [Abstract][Full Text] [Related]
9. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?
Reinsberg J; Krebs D
Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130
[TBL] [Abstract][Full Text] [Related]
10. [Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].
Sugiyama S
Kaku Igaku; 1994 Apr; 31(4):327-36. PubMed ID: 8196229
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
12. Anti-murine antibody response to mouse monoclonal antibodies in cancer patients.
Sakahara H; Saga T; Onodera H; Yao Z; Nakamoto Y; Zhang M; Sato N; Nakada H; Yamashina I; Endo K; Konishi J
Jpn J Cancer Res; 1997 Sep; 88(9):895-9. PubMed ID: 9369938
[TBL] [Abstract][Full Text] [Related]
13. Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.
Uttenreuther-Fischer MM; Feistel H; Wolf F; Jäger W
J Clin Lab Anal; 1997; 11(2):94-103. PubMed ID: 9058243
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of ovarian cancer patients under repeated stimulation of HAMA using MAb OC125 and B43.13.
Baum RP; Noujaim AA; Nanci A; Moebus V; Hertel A; Niesen A; Donnerstag B; Sykes T; Boniface G; Hör G
Hybridoma; 1993 Oct; 12(5):583-9. PubMed ID: 8300134
[No Abstract] [Full Text] [Related]
15. Human antiidiotypic antibodies against OC125 strongly interfere with one-step assays of CA 125 employing OC125 and M11 antibodies.
Reinsberg J; Gast B
Clin Chem; 1994 Jun; 40(6):951-2. PubMed ID: 8087996
[No Abstract] [Full Text] [Related]
16. Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients.
Tibben JG; Thomas CM; Massuger LF; Segers MF; Schijf CP; Corstens FH; Boerman OC
Nucl Med Commun; 1995 Oct; 16(10):853-9. PubMed ID: 8570116
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
Peltier P; Dutin JP; Chatal JF; Fumoleau P; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A
Ann Oncol; 1993 Apr; 4(4):307-11. PubMed ID: 8518221
[TBL] [Abstract][Full Text] [Related]
18. Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay.
Reinsberg J
Clin Biochem; 1996 Apr; 29(2):145-8. PubMed ID: 8601323
[TBL] [Abstract][Full Text] [Related]
19. [A trial with immunotherapy of ovarian cancer by idiotype vaccination. Activation of the idiotype network in patients with advanced ovarian cancers by treatment with monoclonal antibody OC125].
Wagner U; Reinsberg J; Krebs D
Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):785-8. PubMed ID: 2286317
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
Vuillez JP; Peltier P; Mayer JC; Dubois F; Chetanneau A; Fumoleau P; Bertrand A; Chatal JF
J Nucl Med; 1991 Feb; 32(2):221-7. PubMed ID: 1992023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
